Hybrid closed‐loop therapy with a first‐generation system increases confidence and independence in diabetes management in youth with type 1 diabetes
| العنوان: | Hybrid closed‐loop therapy with a first‐generation system increases confidence and independence in diabetes management in youth with type 1 diabetes |
|---|---|
| المؤلفون: | Alison, Roberts, Leanne, Fried, Julie, Dart, Martin, de Bock, Janice, Fairchild, Bruce, King, Geoffrey R, Ambler, Fergus, Cameron, Sybil A, McAuley, Anthony C, Keech, Alicia, Jenkins, David N, O Neal, Elizabeth A, Davis, Timothy W, Jones, Mary B, Abraham |
| المصدر: | Diabetic Medicine. 39 |
| بيانات النشر: | Wiley, 2022. |
| سنة النشر: | 2022 |
| مصطلحات موضوعية: | Adult, Blood Glucose, Young Adult, Diabetes Mellitus, Type 1, Insulin Infusion Systems, Endocrinology, Adolescent, Blood Glucose Self-Monitoring, Endocrinology, Diabetes and Metabolism, Internal Medicine, Humans, Hypoglycemic Agents, Insulin |
| الوصف: | Hybrid closed-loop (HCL) therapy improves glycaemic control in adolescents with type 1 diabetes; however, little is known about their lived experience using these systems. The aim of this study was to explore the lived experiences of youth with type 1 diabetes using HCL therapy, and their parents, to provide insight into their lived experiences.Adolescents and young adults aged 12-25 years, who used Medtronic MiniMed™ 670G HCL system during a 6-month randomised clinical trial, and their parents, were invited to participate in a semi-structured interview at the end of the study. Open-ended questions were used to explore the lived experiences of families using HCL. The interviews were audio-recorded, transcribed and analysed using thematic analysis to determine the main themes.In all, 17 young people with type 1 diabetes mean ± SD age: 17.5 ± 4.2 years, diabetes duration: 11.0 ± 4.9 years and HbABoth youth and parents acknowledged the benefits of this first-generation HCL system in improving glycaemic outcomes and in providing flexibility and independence. These lived experiences provide valuable information in the introduction and provision of targeted education with HCL therapy. |
| تدمد: | 1464-5491 0742-3071 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::979daf0643b4e4c35dbd8b8d5700bbe3Test https://doi.org/10.1111/dme.14907Test |
| حقوق: | CLOSED |
| رقم الانضمام: | edsair.doi.dedup.....979daf0643b4e4c35dbd8b8d5700bbe3 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 14645491 07423071 |
|---|